A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1

Histone deacetylase (HDAC) inhibitors are considered novel agents for cancer chemotherapy. We previously investigated MHY219, a new HDAC inhibitor, and its potent anticancer activity in human prostate cancer cells. In the present study, we evaluated MHY219 molecular mechanisms involved in the regula...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Umasankar, Kundu, Soma, Patra, Nabanita, Ahn, Mee Young, Ahn, Ji Hae, Son, Ji Yeon, Yoon, Jung Hyun, Moon, Hyung Ryoung, Lee, Byung Mu, Kim, Hyung Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556203/
https://www.ncbi.nlm.nih.gov/pubmed/26336583
http://dx.doi.org/10.4062/biomolther.2015.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556203/
https://www.ncbi.nlm.nih.gov/pubmed/26336583
http://dx.doi.org/10.4062/biomolther.2015.026

Ejemplares similares